3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
91
Leukemia, Lymphocytic, Chronic, B-Cell
28
Myelodysplastic Syndromes
18
Recurrence
9
Lymphoma, Mantle-Cell
9
Leukemia, Biphenotypic, Acute
8
Burkitt Lymphoma
8
Waldenstrom Macroglobulinemia
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Leukemia, Myelomonocytic, Chronic
7
Leukemia
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Neoplasms
6
Lymphoma, Non-Hodgkin
6
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, B-Cell, Marginal Zone
6
Lymphoma
6
Hematologic Neoplasms
6
Lymphoma, Follicular
4
Myeloproliferative Disorders
3
Multiple Myeloma
3
Anemia, Refractory, with Excess of Blasts
3
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, B-Cell
2
Leukemia, Myeloid
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Blast Crisis
2
Venentoclax
1
Targeted Therapy
1
Sarcoma, Myeloid
1
Interventions
Nivolumab
3
tivozanib
1
regorafenib
1
neratinib
1
lutetium Lu 177 dotatate
1
encorafenib
1
durvalumab
1
capivasertib
1
Valproic Acid
1
Thioctic Acid
1
Oxaliplatin
1
Multiparametric Magnetic Resonance Imaging
1
Leucovorin
1
Lenalidomide
1
Gemcitabine
1
Fulvestrant
1
Folfox protocol
1
Fluorouracil
1
Cisplatin
1
Cetuximab
1
Bortezomib
1
Blood Specimen Collection
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Disease Progression
×
venetoclax
×
90 days
×
Clear all
No trials found.